Showing results (171-180 of 482) with videos related to
Sort By:
Pageof 49
Human Molecular Genetics|August 2, 2013
Deciphering the genetic architecture of low-penetrance susceptibility to colorectal cancerNicola Whiffin, Sara E Dobbins, Fay J Hosking, et al.American Journal of Human Genetics|September 2, 2008
Runs of homozygosity in European populationsRuth McQuillan, Anne-Louise Leutenegger, Rehab Abdel-Rahman, et al.Inflammatory Bowel Diseases|February 8, 2007
Contribution of the NOD1/CARD4 insertion/deletion polymorphism +32656 to inflammatory bowel disease in Northern EuropeJ Van Limbergen, R K Russell, E R Nimmo, et al.Proceedings of the National Academy of Sciences of the United States of America|February 28, 2002
Whole-gene APC deletions cause classical familial adenomatous polyposis, but not attenuated polyposis or "multiple" colorectal adenomasO M Sieber, H Lamlum, M D Crabtree, et al.Gut|November 28, 2024
Genetic variation at 11q23.1 confers colorectal cancer risk by dysregulation of colonic tuft cell transcriptional activator POU2AF2Vidya Rajasekaran, Bradley T Harris, Ruby T Osborn, et al.BMC Medicine|August 15, 2018
Exploring causality in the association between circulating 25-hydroxyvitamin D and colorectal cancer risk: a large Mendelian randomisation studyYazhou He, Maria Timofeeva, Susan M Farrington, et al.Plos One|June 22, 2018
Coding variants in NOD-like receptors: An association study on risk and survival of colorectal cancerStefanie Huhn, Miguel I da Silva Filho, Tharmila Sanmuganantham, et al.Gut|December 11, 2019
Systematic meta-analyses, field synopsis and global assessment of the evidence of genetic association studies in colorectal cancerZahra Montazeri, Xue Li, Christine Nyiraneza, et al.Carcinogenesis|April 2, 2005
Aurora-A/STK15 T+91A is a general low penetrance cancer susceptibility gene: a meta-analysis of multiple cancer typesAmanda Ewart-Toland, Qi Dai, Yu-Tang Gao, et al.Nature Communications|November 9, 2019
AZD7648 is a potent and selective DNA-PK inhibitor that enhances radiation, chemotherapy and olaparib activityJacqueline H L Fok, Antonio Ramos-Montoya, Mercedes Vazquez-Chantada, et al.Pageof 49